Ieq Capital LLC Invests $907,000 in Ardent Health, Inc. $ARDT

Ieq Capital LLC acquired a new stake in Ardent Health, Inc. (NYSE:ARDT) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 92,191 shares of the company’s stock, valued at approximately $907,000. Ieq Capital LLC owned 0.06% of Ardent Health as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in the business. The Manufacturers Life Insurance Company boosted its position in Ardent Health by 3.7% during the first quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock worth $255,000 after purchasing an additional 1,072 shares during the period. Geode Capital Management LLC lifted its stake in shares of Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after buying an additional 1,769 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in Ardent Health by 8.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 27,530 shares of the company’s stock worth $376,000 after buying an additional 2,110 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in Ardent Health by 1,177.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after buying an additional 2,638 shares during the period. Finally, Allworth Financial LP purchased a new position in Ardent Health in the 2nd quarter valued at approximately $28,000.

Insiders Place Their Bets

In other Ardent Health news, CFO Alfred Lumsdaine purchased 10,000 shares of the stock in a transaction on Friday, June 5th. The shares were purchased at an average price of $8.81 per share, with a total value of $88,100.00. Following the acquisition, the chief financial officer directly owned 329,183 shares in the company, valued at approximately $2,900,102.23. The trade was a 3.13% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.90% of the stock is owned by corporate insiders.

Ardent Health Stock Performance

NYSE ARDT opened at $10.96 on Friday. The company’s 50 day simple moving average is $10.51 and its two-hundred day simple moving average is $9.75. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. Ardent Health, Inc. has a 1 year low of $7.71 and a 1 year high of $15.48. The stock has a market capitalization of $1.55 billion, a PE ratio of 19.94, a P/E/G ratio of 3.15 and a beta of 0.70.

Ardent Health (NYSE:ARDT) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. The firm had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Analysts predict that Ardent Health, Inc. will post 0.97 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on ARDT shares. Truist Financial increased their target price on Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. UBS Group boosted their price objective on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research note on Thursday, May 7th. Weiss Ratings cut Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. Finally, Guggenheim raised their target price on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $13.05.

Ardent Health Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.